DaVita Inc. announced today its offer to exchange $225 million of its 9 1/4% Senior Subordinated Notes due 2011, which have been registered under the Securities Act of 1933, for its outstanding 9...
We are planning to release our second quarter financial results on Thursday, August 2, 2001. A conference call to discuss the Q2 operating results is scheduled for 10:30 a.m. Pacific Time on...
DaVita Inc. announced today that Nancy-Ann DeParle and William L. Roper have joined its Board of Directors. As expected, Thomas A. Scully has resigned his position on the DaVita Board of Directors...
Contact: LeAnne Zumwalt Investor Relations Total Renal Care, Inc. 310-792-2600 ext. 2072 Thursday May 10, 6:59 am Eastern Time TORRANCE, Calif., May 10 (Reuters) - DaVita Inc. (NYSE:DVA), an...
DaVita Inc. announced that it has received notice that Amgen Inc. has increased the Wholesaler Acquisition Price for EPOGEN by 3.9%, effective May 9, 2001 at 5:01 PM Pacific Time. This pricing...